🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-18
Trial ID
NCT06878833
Treatments Being Tested
This study will evaluate the safety and efficacy of SJP-0132 in Chinese Pat...
Status
Completed
Location
Beijing Hospital
Start Date
2024-12-30
Trial ID
NCT06717152
This is a two stage study, with an initial dose escalation phase I study an...
Status
Active Not Recruiting
Location
Velindre NHS Trust
Start Date
2014-05-07
Trial ID
NCT01992952
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of rabe...
Status
Completed
Location
New York Center For Clinical Research
Start Date
2005-10
Trial ID
NCT00236197
Treatments Being Tested
This study is a two-period, double-blind study in healthy adult female subj...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-09-14
Trial ID
NCT01195974
Treatments Being Tested
This study will examine the safety and efficacy of the addition of sitaglip...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00885352
Treatments Being Tested
To investigate the efficacy and safety after administration of HCP1105 in h...
Status
Unknown
Location
Euljii General Hospital
Start Date
2014-10
Trial ID
NCT02551172
Treatments Being Tested
A 52-week study to compare the efficacy of relamorelin with that of placebo...
Status
Terminated
Location
Pinnacle Research Group
Start Date
2018-02-01
Trial ID
NCT03383146
Treatments Being Tested
This study investigates the safety, pharmacokinetics and effects of GSK1292...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09-14
Trial ID
NCT01218204
The purpose of this placebo-controlled, double-blind study is to assess the...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02608697
Treatments Being Tested